Companies: 10,795·Total market cap: $144.5T
CEN Biotech, Inc.

CEN Biotech, Inc.

CENBFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$6526
P/E Ratio
52W High$0.0002
52W Low$0.00001

CEN Biotech, Inc.(CENBF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CENBF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$0.99M$0.63M$0.00M$0.00M$0.00M
Cost of Revenue$0.49M$0.00M$0.44M$2.58M$4.37M
Gross Profit$0.50M$0.63M($0.44M)($2.58M)($4.37M)
Gross Margin %(computed)50.45%100.00%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M$0.04M
G&A Expenses$2.25M$18.33M$2.21M$2.58M$3.10M
Total Operating Expenses$1.76M$19.66M$1.77M$2.58M$3.10M
Operating Income($1.26M)($19.04M)($2.21M)($2.58M)($3.10M)
Operating Margin %(computed)-128.15%
Interest Income$0.00M$0.00M$0.01M$0.01M$0.01M
Interest Expense$0.25M$0.85M$3.68M$3.31M$2.87M
Income Before Tax($1.51M)($18.94M)$14.25M($5.66M)($7.53M)
Income Tax Expense$0.00M($0.04M)$0.00M$0.00M($0.29M)
Net Income($1.51M)($18.90M)$14.25M($5.66M)($7.53M)
Net Margin %(computed)-153.48%
Per Share & EBITDA
EPS (Basic)$-0.02$-0.45$0.52$-0.35$-0.30
Wtd Avg Shares64.74M42.42M31.44M26.36M25.30M
EBITDA($0.77M)($17.63M)$18.36M($1.90M)($4.22M)
EBITDA Margin %(computed)-78.31%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解CEN Biotech, Inc.

关于CEN Biotech, Inc.(CENBF)损益表

CEN Biotech, Inc.(CENBF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,CENBF实现营收$0.00B,毛利润$0.00B(毛利率50.45%),净利润($0.00B)(净利率-153.48%)。

常见问题

CENBF · 4 问

CEN Biotech, Inc.(CENBF)2022财年营收为$0.00B,同比up57.5%。

CENBF revenueCENBF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09